Skip to search formSkip to main contentSkip to account menu

Metastatic Non-Squamous Non-Small Cell Lung Carcinoma

Known as: Metastatic Non-Squamous Non-Small Cell Lung Cancer 
A non-squamous non-small cell carcinoma that arises from the lung and has metastasized to another anatomic site.
National Institutes of Health

Related topics

Related topics

14 relations
ChestEGFR Gene MutationEGFR geneEpithelial Cells

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
A real-world analysis of non-small cell lung cancer patients treated with pembrolizumab or pembrolizumab in combination with pemetrexed and platinum.
53Background: Pembrolizumab (Pembro) is used in first-line treatment of patients with metastatic non-squamous non-small cell lung… 
Review
2019
Review
2019
Exceptional pemetrexed sensitivity can predict therapeutic benefit from subsequent chemotherapy in metastatic non-squamous non-small cell lung cancer
PurposeBased on an exceptionally durable response to pemetrexed observed in some patients with metastatic NSCLC, the predictive… 
2018
2018
A phase III, randomized, open-label, multicenter study of SHR-1210 (anti-PD-1 antibody) in combination with pemetrexed and carboplatin as first line therapy in subjects with advanced/metastatic non…
2016
2016
A phase 1b study of famitinib plus docetaxel as 2nd line setting in patients with metastatic non-squamous non-small cell lung cancer and EGFR wild type.
e20603Background: This phase Ib study was designed to evaluate the safety and efficacy of famitinib plus docetaxel in previously… 
2015
2015
Sequential administration of vinorelbine plus cisplatin and bevacizumab followed by docetaxel plus gemcitabine and bevacizumab compared to docetaxel plus cisplatin and bevacizumab regimen as first…
2014
2014
A randomised phase II study of pemetrexed versus pemetrexed+erlotinib as second-line treatment for locally advanced or metastatic non-squamous non-small cell lung cancer.
2014
2014
P0066 A randomised phase 3 study comparing first-line pemetrexed plus cisplatin followed by gefitinib as maintenance with gefitinib monotherapy in east Asian patients with locally advanced or…
2013
2013
Pemetrexed-induced anaphylaxis
Pemetrexed is a folate antimetabolite approved for the treatment of mesothelioma and locally advanced or metastatic non-squamous… 
2009
2009
Phase II study of bevacizumab in combination with cisplatin and docetaxel as first-line treatment of patients (p) with metastatic non-squamous non-small cell lung cancer (NSCLC).
e19023 Background: Bevacizumab (B), in addition to platinum-based chemotherapy, is indicated for 1st-line treatment of p with… 
2008
2008
EGFR mutations and gefitinib sensitivity in patients with metastatic non-squamous non-small cell lung cancer
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)